Related Experiment Video

Updated: Jan 2, 2026

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

791

Increased Psychiatric Risk in Children After Pediatric Intensive Care Unit Admission

Hanaa I Rady1, Omnia Raafat Ismail2, Mohammed Safwat Abdelkader1

  • 1Departments of Pediatrics.

The Journal of Nervous and Mental Disease
|December 14, 2019
PubMed

Insights

Children admitted to pediatric intensive care units (PICUs) face a higher risk of psychiatric issues. PICU survivors showed significantly increased rates of posttraumatic stress disorder (PTSD), anxiety, and depression compared to general ward patients.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Child Psychiatry
  • Psychological Trauma

Background:

  • Admission to a pediatric intensive care unit (PICU) can be a traumatic experience for children.
  • Understanding the long-term psychiatric consequences for these children is crucial for effective care.

Purpose of the Study:

  • To evaluate the psychiatric risk and morbidity in children following PICU admission.
  • To compare psychiatric outcomes between children discharged from PICU and those from general wards.

Main Methods:

  • A cross-sectional study involving 130 children aged 6-13 years.
  • Two groups were compared: 65 children from PICU and 65 from general wards.
  • Standardized assessments included PTSD (DSM-5, IES-R), anxiety (RCMAS), and depression (Birleson Depression Scale).

Main Results:

  • Children discharged from the PICU exhibited worse scores across all measured psychiatric morbidity scales.
  • Significantly higher frequencies of posttraumatic stress disorder (PTSD) were observed in the PICU group (84.6%) compared to the general ward group (6.2%).
  • The PICU group showed elevated rates of anxiety and depression.

Conclusions:

  • PICU survivors face a substantially higher risk of developing psychiatric morbidities, including PTSD, anxiety, and depression.
  • Early identification and intervention for psychiatric issues in PICU survivors are warranted.
  • Further longitudinal research is recommended to understand the trajectory of these psychiatric conditions.

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.4K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
210
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
196
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
417
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
173
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
680
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
154